Sold as Avagard. Every FDA application for this active ingredient.
As of Nov 15, 2026, FDA lists 1 application for Alcohol; Chlorhexidine Gluconate (sold as Avagard), first approved Jun 7, 2001, with 0 new uses approved and 0 published complete response letters.
| Effectiveness of Pre-Procedural CPC and Zinc Mouthwash in Reducing Dental AerosolsBacterial Contamination · Colgate Palmolive | Phase 4 | Not yet recruiting | Oct 19, 2026 |
| Oral Hygiene Assistance Training ProgramElderly, Periodontal Disease · Colgate Palmolive | Phase 4 | Not yet recruiting | Sep 8, 2026 |
| The IVCare Adaptive Platform TrialDevice Related Infection, Vascular Access Complication · The University of Queensland | Not applicable | Not yet recruiting | May 14, 2026 |
| Effects of Percutaneous Neuromodulation on Vertical JumpHealthy Athletes · CEU San Pablo University | Not applicable | Active, not recruiting | Apr 13, 2026 |
| Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated InfectionNeonatal Sepsis · Alexandria University | Not applicable | Recruiting | Feb 19, 2026 |
| Physical Activity and Insulin Sensitivity DynamicsInsulin Sensitivity · University of Copenhagen | Not applicable | Recruiting | Jan 15, 2025 |
| A Prospective Cohort Study to Evaluate the Safety, Efficacy, and Usability of the EpiZact DevicePostdural Puncture Headache, Epidural Analgesia, Obstetric · Oregon Health and Science University | Phase 4 | Not yet recruiting | Dec 11, 2024 |
| Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous CathetersPediatric Cancer · Dokuz Eylul University | Not applicable | Recruiting | Dec 6, 2024 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Solventum